Detection of Benign and Malignant Thyroid and Breast Tumors by Fourier Transform Infrared Spectrometry

NCT01668238 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2012-08-20

No results posted yet for this study

Summary

The purpose of this stage of study is to establish discriminant among healthy tissue, benign and malignant thyroid and breast tumors by fourier transform infrared spectrometry variables.

Conditions

  • Thyroid Tumor
  • Breast Tumor

Sponsors & Collaborators

  • Peking University

    collaborator OTHER
  • XU Zhi

    lead OTHER

Principal Investigators

  • Zhi Xu, PhD MD · Peking University Third Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01668238 on ClinicalTrials.gov